Linezolid injection further expands the Fresenius Kabi anti-infective portfolio. It is available in the company's proprietary Freeflex® bag.

University Hospital of Munich has joined the growing “Wir für Gesundheit” hospital network, becoming the first university clinic to accept PlusCard. Through its supplementary company health insurance, PlusCard offers employers coverage options that provide employees with different levels of service and comfort. “Wir für Gesundheit” was formed by hospital operators Asklepios, Fresenius Helios and Rhön, and has more than 120 partner hospitals in Germany committed to quality standards far higher than those required by law.

Vamed is realizing the new main building of University Hospital Schleswig-Holstein in Kiel, Germany as part of a public-private partnership. The company will also be responsible for the long-term technical management of the building, which will house more than 600 beds and 22 operating rooms. The work is part of a comprehensive construction and modernization project at the hospital. Completion is scheduled for 2019.

Amikacin Sulfate Injection, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.

After nine months of construction, a new central sterilization unit has been opened at HELIOS Hospital Dr. Horst Schmidt Kliniken in Wiesbaden, Germany. Up to 75,000 medical instruments will be cleaned and sterilized annually in the unit, for use in five HELIOS hospitals. The total investment was about €4 million.

Medical progress is steadily increasing life expectancy for cancer patients. A study by VAMED of some 1,000 cancer patients in Austria shows that rehabilitation is improving their quality of life. Cases of depression fell by half after oncological rehabilitation, according to the study, carried out at VAMED’s rehabilitation center in St. Veit, Austria. Anxiety about a possible recurrence of cancer fell by a similar amount. Fresenius Vamed operates 15 rehabilitation centers in Europe.

Dexmedetomidine Hydrochloride Injection, a sedative, further expands the company's anesthesia portfolio.

Fresenius Helios has presented the plan for its new main building at HELIOS Hospital Dr. Horst Schmidt in the German city of Wiesbaden. The seven-story structure, with total floor space of almost 100,000 square meters (more than 1 million square feet), will be built on an open site near the existing hospital building. Patients’ waiting times and the distances they need to cover will be significantly reduced in the new building, which will have 22 operating rooms and more than 900 beds. Construction is scheduled to start next spring, with completion in 2020. Building costs are estimated at around €200 million.

Fresenius Medical Care has opened its China Design Center, in Caohejing Hi-Tech Park in Shanghai. The new facility represents a ramping-up of research and development activities outside of Europe and the United States, and underscores Fresenius Medical Care’s commitment to making its world-leading dialysis treatments and technologies more widely available to patients in China and other emerging markets. In addition to developing a deeper insight into the needs of these markets, the company aims to provide even more innovative and cost-effective solutions for treating kidney disease.

HELIOS Hospital Dr. Horst Schmidt, in the German city of Wiesbaden, will begin training about 160 students annually in nursing and other patient care occupations. The internal continuing education program for all employees now includes more than 2,000 different courses. HELIOS has invested about €3 million in new facilities for the training center, which will include seven modern teaching rooms, practice rooms, and a library.